Clinical trial
Phase 2 Study of Weekly Topotecan With Docetaxel for Recurrent Small Cell Lung Cancer
NCT00315211 is registered in ClinicalTrials.gov with Aultman Health Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study of Weekly Topotecan With Docetaxel for Recurrent Small Cell Lung Cancer
- Lead sponsor
- Aultman Health Foundation
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2004
- Completion date
- November 8, 2007
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.